Availability and Content of Clinical Guidance for Tobacco Use and Dependence Treatment - United Stat
Tuesday, October 25, 2022
Posted by: Natalia Gromov
VanFrank B, Uhd J, Savage
TR, Shah JR, Twentyman E.
Availability and Content
of Clinical Guidance for Tobacco Use and Dependence Treatment - United States,
2000-2019.
[published online ahead of print, 2022 Sep 22]. Prev Med. 2022;164:107276.
doi:10.1016/j.ypmed.2022.107276
Evidence-based treatments for tobacco use and dependence can increase cessation
success but remain underutilized. Health professional societies and voluntary
health organizations (advising organizations) are uniquely positioned to
influence the delivery of cessation treatments by providing clinical guidance
for healthcare providers. This study aimed to review the guidance produced by
these organizations for content and consistency with current evidence.
Documents discussing healthcare providers' role in treatment of tobacco use and
dependence produced by US-based advising organizations between 2000 and 2019
were identified in both peer-reviewed and grey (i.e., informally or
non-commercially published) literature. Extraction of variables, defined in
terms of healthcare provider role and endorsement of specific treatment(s), was
completed by two independent reviewers. Review of 38 identified documents
sponsored by 57 unique advising organizations revealed deficits in the
direction of comprehensive care and incorporation of the most recent evidence
for treatment of tobacco use and dependence. Documents endorsed: screening
(74%), pharmacotherapy (68%), counseling (89%), or follow-up (37%). Few
documents endorsed more recent evidence-based treatments including combination
nicotine replacement therapy (18%), and text- (11%) and web-based (11%)
interventions. Advising organizations have opportunities to address identified
gaps and enhance clinical guidance to contribute toward expanding the provision
of comprehensive tobacco cessation support.
|
|
Email to a Friend